44
Participants
Start Date
April 30, 2004
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Pamidronate
The study was a randomized, double blind, dose-escalation trial of IV pamidronate. Study participants were divided among four study phases. Each group received IV placebo or escalating doses of IV pamidronate of 30mg, 60mg, 90mg and 180mg.
Mount Sinai Medical Center, New York
Pappagallo, Marco, M.D.
INDIV